The TRANSFORM-2 study found patients receiving Spravato were 70% more likely to achieve remission than those on a newly initiated oral antidepressant plus placebo
Spravato Treatment in Cinco Ranch, TX: FDA-Approved Relief for Treatment-Resistant Depression
Find the best Spravato treatment clinic serving Cinco Ranch, TX at Catalyst Health & Wellness — a trusted, REMS-certified Houston provider of the only FDA-approved nasal spray for treatment-resistant depression. Led by Dr. Ho, board-certified anesthesiologist and former pediatrician. Three Houston locations open Monday–Sunday, 5am–9pm.
Recover Fully with Spravato Treatment Cinco Ranch
Cinco Ranch was designed from the ground up to be one of Houston’s premier master-planned communities — the trails, the lakes, the Katy ISD schools, the meticulous attention to what makes a neighborhood genuinely livable. It’s a community that attracts people who are intentional about their quality of life. But even in one of the most thoughtfully planned communities in the greater Houston area, treatment-resistant depression doesn’t follow the plan. It doesn’t yield to intention or effort, and it doesn’t respond to antidepressants that target the wrong neurological system.
If you’ve tried multiple medications without finding lasting relief, you’re not dealing with a failure of effort — you’re dealing with a mismatch between your brain’s biology and the mechanism of every treatment you’ve been offered. At Catalyst Health & Wellness, we serve Cinco Ranch residents — and patients from the Katy area, Fulshear, Westheimer Corridor, and greater west Houston — as a fully REMS-certified Spravato provider. Spravato (esketamine) is the only FDA-approved nasal spray built for treatment-resistant depression, and Massachusetts General Hospital’s Ketamine Clinic — one of the most respected research programs in psychiatric medicine — offers intravenous ketamine and esketamine treatment specifically because “both forms of treatment have been shown to work in patients with treatment-resistant depression who have failed four or more antidepressant trials.” With Dr. Ho’s clinical expertise, comprehensive insurance support, and a schedule built for Cinco Ranch residents’ demanding lives, Catalyst brings that clinical breakthrough within reach.
What is Spravato Therapy?
Spravato (esketamine) earned FDA breakthrough therapy designation before receiving full approval in 2019 — the first new antidepressant mechanism introduced in more than 30 years. The FDA expanded that approval in 2020 to include adults with major depressive disorder experiencing active suicidal ideation or behaviors. Then in January 2025, the FDA approved Spravato as a standalone monotherapy for TRD — meaning qualifying patients can now benefit from Spravato even without a simultaneously prescribed oral antidepressant, making it the first and only monotherapy for adults with treatment-resistant depression.
Research consistently shows powerful results:
What Our Patients Say
Take the First Step Toward Healing
Book Appointment
Conditions We Treat with Spravato Therapy in Cinco Ranch
Spravato holds FDA approval for two specific, well-defined clinical indications — every qualifying Cinco Ranch patient receives a treatment with a thoroughly established safety and efficacy record. At Catalyst Health & Wellness, we offer Spravato for:
Your Spravato Therapy Journey at Catalyst Health & Wellness
Every step of the Spravato process at Catalyst has been designed to be clear, supported, and genuinely manageable for Cinco Ranch patients with demanding schedules and full lives. Here's what to expect.
Step 1: Free Phone Consultation
Your first conversation with our team costs nothing. A clinical team member will walk through your depression history, your medication background, and what daily life looks like today. You’ll receive an honest assessment of whether Spravato is a realistic fit — including an honest answer if it isn’t.
Step 2: Insurance Verification & Prior Authorization
Spravato is often covered by insurance for qualifying patients, but prior authorization is nearly always required. Our team handles that entirely: verifying benefits, preparing documentation, submitting the authorization, and following up with your insurer until it’s approved. You focus on the decision; we manage the process.
Step 3: Before Your First Visit
Before your appointment, we’ll cover everything: dietary guidelines, what to bring, how to arrange transportation, and timing notes for current medications. Nothing about your first session will be unclear before you walk in.
Step 4: Day of Treatment
Plan for approximately two to two-and-a-half hours per visit. You’ll need a designated driver or pre-arranged rideshare — driving on treatment days is not permitted. Come comfortable and ready to rest. That’s the full scope of what preparation requires.
Step 5: Your Treatment Session
You’ll settle into a private, purpose-built treatment room — reclinable chair, soft adjustable lighting, warm blankets, noise-cancelling headphones if you want them. Spravato is self-administered as a nasal spray under direct clinical supervision. Dr. Ho’s team monitors your vital signs, blood pressure, and overall response throughout. Temporary effects — mild dissociation, light-headedness — are expected and typically resolve within the two-hour observation window.
Step 6: Recovery & Aftercare
After monitoring ends, you’ll leave with your driver. Driving should wait until the morning after a full night’s sleep. Our team follows up between sessions to track your response and make any needed adjustments before your next visit.
Step 7: Treatment Schedule & Maintenance
The protocol begins with twice-weekly sessions during weeks one through four, steps to once weekly in weeks five through eight, then transitions to individualized maintenance — weekly, every two weeks, or monthly — based on your response. Your progress guides the schedule, not a calendar.
The Science Behind Spravato for Treatment-Resistant Depression
Spravato’s FDA approvals rest on a robust clinical evidence base anchored by two pivotal randomized controlled trials and validated through a decade of real-world use and international regulatory review.
The TRANSFORM-2 study, published in the American Journal of Psychiatry, enrolled patients with confirmed treatment-resistant depression in a double-blind comparison of flexibly-dosed Spravato plus a newly initiated oral antidepressant versus antidepressant plus placebo. Patients receiving Spravato were 70% more likely to achieve remission. Statistically significant improvement was measurable within 24 hours of the first dose — before the co-administered antidepressant could have reached therapeutic effect. That 24-hour window reflects the glutamate cascade’s speed: synaptogenesis in the prefrontal cortex begins within hours of NMDA receptor blockade, producing neuroplasticity that monoamine-targeting treatments simply don’t generate.
The SUSTAIN-1 trial, published in JAMA Psychiatry, demonstrated that those gains hold with continued treatment. Patients who achieved stable remission or response were randomized to continue Spravato or transition to placebo. Those who continued treatment had significantly longer time to relapse — a hazard ratio of 0.49 (p=0.003). Maintenance treatment isn’t a formality; it’s a clinically meaningful investment in sustaining what patients achieve during induction.
Key research findings:
- Spravato drives synaptogenesis and neuroplasticity in prefrontal cortex and other mood-regulating brain regions within hours of the first dose — active neural repair rather than incremental chemical adjustment
- The ASPIRE I and II trials confirmed statistically significant depressive symptom reduction within 24 hours in patients with MDD and active suicidal ideation — the first FDA-approved rapid-response pharmacological option for that clinical population
- MGH’s Ketamine Clinic observes that both ketamine and esketamine work for patients who have failed four or more antidepressant trials — a real-world clinical observation that aligns with the mechanistic understanding of why glutamate-targeting treatments succeed where monoamine-targeting approaches have not
- Spravato’s FDA approval as a standalone monotherapy in January 2025 represents the most recent milestone in its expanding evidence base, adding a new clinical pathway for patients who cannot tolerate or do not want to continue oral antidepressants
Why Choose Catalyst Health & Wellness for Spravato Treatment in Cinco Ranch
01
REMS-Certified Provider
The FDA requires all Spravato administrations to occur in a certified healthcare setting under its Risk Evaluation and Mitigation Strategy (REMS) program. Catalyst Health & Wellness holds full REMS certification across all three Houston locations. Cinco Ranch patients receive treatment that meets every federal safety requirement, every session, without exception.
02
Led by Dr. Ho – Expert Medical Care
Dr. Ho’s credentials align precisely with what safe Spravato treatment demands. His board certification in anesthesiology means deep, hands-on expertise in esketamine pharmacology, clinical dosing, and the physician-level monitoring that administering an NMDA antagonist in a clinical setting requires. His background as a former pediatrician defines the culture of the entire clinic — patient-centered, unhurried, attentive to how treatment feels from the patient’s perspective rather than just how it tracks on a scale. Cinco Ranch patients who have invested in quality in every other area of their lives deserve that same standard from their mental health care.
03
Insurance Navigation Support
Spravato stands apart from most advanced mental health treatments because major commercial insurance plans and Medicare frequently cover it for qualifying patients. Prior authorization is nearly always part of the process, and the documentation requirements can feel overwhelming when you’re already managing depression. Our team handles it entirely: benefit verification, prior auth submission, insurer follow-up, and appeals. We’ve done this across dozens of plans. Your energy belongs to your recovery.
04
Whole-Person Approach
From the first call, our focus is on understanding you as a complete person — your full treatment history, your current circumstances, what you’re hoping to get back. Treatment plans are shaped by that full picture and updated as your response evolves. What this means for you:
- Plans personalized to your specific history and present situation
- Ongoing adjustments based on real response data, not a standard protocol
- Active coordination with your existing psychiatrist or prescribing physician
- Long-term engagement that extends well beyond the initial induction series
05
Extended Hours & Flexible Scheduling
Each Spravato session requires two or more hours in clinic. For Cinco Ranch residents managing professional careers, active family lives, and long commutes through the Katy corridor, finding a two-hour clinical window in a standard schedule is genuinely difficult. Our 5am to 9pm hours, seven days a week at all three Houston locations, solve that. Pre-dawn appointments before the commute, evening sessions after responsibilities end, weekend treatment — all available. If your schedule has been the obstacle between you and care you need, we’ve removed it.
06
Comprehensive Treatment Options
Spravato is a powerful tool, but it’s not the only one. When your clinical picture benefits from a multi-modal approach, Catalyst offers complementary evidence-based treatments under the same roof:
Ketamine Therapy
Broader applications including anxiety, PTSD, chronic pain, OCD, and bipolar depression
TMS Therapy
Non-invasive magnetic brain stimulation for depression and OCD
Stellate Ganglion Block
Targeted nerve block treatment for PTSD and anxiety
Our goal is to find the right combination of treatments for your unique situation — not to fit you into a one-size-fits-all protocol.
07
Safe, Comfortable Environment
Our treatment rooms were built for the Spravato experience, not repurposed from other clinical uses. Each is private, quiet, and purpose-designed: reclinable chairs, soft adjustable lighting, warm blankets, noise-cancelling headphones. Dr. Ho’s clinical team is present and monitoring throughout every session. You’re observed, supported, and never alone during treatment.
Getting Started with Spravato Treatment in Cinco Ranch
Cinco Ranch residents are accustomed to choosing the best available option in the categories that matter most to them. If treatment-resistant depression has been the one area where that standard hasn’t been met — where the options tried have fallen short — Spravato offers a clinically proven, FDA-approved path forward available right now, from a clinic your community can reach.
Call us at 800-772-1242 for your free, no-obligation phone consultation. We’ll talk through your history honestly, answer every question, and give you a clear picture of whether Spravato is the right fit for your situation. No charge, no pressure, complete confidentiality.
Three Houston locations serve Cinco Ranch patients, with the Heights and Southwest locations both accessible from I-10 and the Katy Freeway. Our 5am to 9pm hours every day of the week ensure treatment fits around your life. Dr. Ho and the entire Catalyst team are ready when you are.
Monday-Sunday, 6am-9pm
Free consultation
Insurance assistance
Three Houston locations
REMS-certified provider
Commonly Asked Questions
Get Help NowHow quickly does Spravato therapy work?
Many patients notice improvements within hours or days of their first treatment. The TRANSFORM-2 study showed significant improvement compared to placebo within 24 hours. This rapid action is one of Spravato’s most remarkable qualities, especially compared to traditional antidepressants that can take 4 to 8 weeks to work.
Is Spravato therapy safe?
Yes, when administered by trained medical professionals in a REMS-certified setting. Spravato underwent extensive clinical trials before FDA approval. Common side effects like dissociation, dizziness, and temporary blood pressure increases typically resolve within 1-2 hours. We monitor your vital signs throughout treatment to ensure your safety.
How many treatments will I need?
During the first month, you’ll receive Spravato twice weekly. In the second month, treatment typically decreases to once weekly. After that, most patients continue with maintenance treatments once weekly or every two weeks. The exact frequency depends on your individual response. We’ll work with you to find the schedule that keeps you feeling your best.
What does Spravato treatment feel like?
Experiences vary from person to person. Many patients describe feeling relaxed, calm, or somewhat disconnected from their surroundings. Some people experience mild visual or sensory changes. These effects are temporary and typically resolve within 1-2 hours after treatment ends. Most patients find the experience manageable and therapeutic.
Can I drive after a Spravato treatment?
No, you cannot drive yourself home after Spravato treatment, and you should not drive until the next day after a restful night’s sleep. You’ll need to arrange transportation both to and from your appointment. By the time you leave our facility after the 2-hour observation period, you’ll feel much clearer, but driving remains unsafe until the following day.
Will my insurance cover Spravato?
Many insurance plans cover Spravato for qualifying patients since it’s FDA-approved for treatment-resistant depression. Coverage varies by plan and typically requires prior authorization. Our team handles the insurance process for you, including benefits verification and prior authorization submissions.
Can I continue my current medications?
Spravato is always used alongside an oral antidepressant, so you’ll continue taking your prescribed antidepressant medication. We’ll coordinate with your prescribing physician to ensure your overall treatment plan is optimized. Some medications may require adjustment before starting Spravato, which we’ll discuss during your consultation.
Do I need a referral from my doctor?
No, you don’t need a referral to begin Spravato therapy at Catalyst Health & Wellness. However, coordination with your current prescribing physician is important since Spravato must be used alongside an oral antidepressant. We encourage communication between all members of your healthcare team.
Our Locations
Blog & insight
Insights on Healing, Growth, and Mental Wellness
June 13, 2026
FAQ: Common Questions About Ketamine Treatment Answered
If you've been researching ketamine therapy in Houston, chances are you've come across a lot of conflicting information. One article calls it a miracle cure. Another paints it as a risky party drug. Somewhere in between sits the truth, and you deserve straightforward answers before making any decision about your mental health or chronic pain…
June 10, 2026
Can Ketamine Therapy Help with Both Depression and Anxiety?
If you've spent years battling depression only to find anxiety creeping in alongside it (or vice versa), you're not imagining the connection. These two conditions show up together far more often than people realize, and the overlap can make recovery feel like trying to untangle a knot that keeps tightening. Traditional antidepressants and anti-anxiety medications…
June 7, 2026
Neuropathic Pain and Ketamine: Relief When Nerve Pain Won’t Quit
If you live with neuropathic pain, you already know it doesn't behave like ordinary pain. It burns when nothing touched you. It shocks down your leg while you're sitting still. It turns the brush of a bedsheet into something sharp. And the medications your doctor prescribed, the gabapentin, the duloxetine, maybe even opioids, take the…
Make an Appointment
Our mission is to empower individuals to overcome life’s challenges through professional psychological support.